Tianjin Ringpu Bio-technology Co., Ltd. Class A · SZSE:300119

Tianjin Ringpu Bio-technology Co., Ltd. Class A financial statements

Tianjin Ringpu Bio-technology Co., Ltd. Class A's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue3.40B3.07B2.71B2.08B2.01B2.00B1.47B1.19B1.05B969.9M
Cost of revenue2.00B1.82B1.53B1.07B969.3M920.8M700.4M593.9M492.1M413.6M
Gross profit1.40B1.25B1.18B1.01B1.04B1.08B766.2M596.0M555.2M556.2M
Research and development253.0M206.6M172.9M132.7M117.7M111.5M94.8M80.3M85.3M76.6M
Selling, general and administrative351.1M188.9M174.0M142.8M150.3M165.1M141.4M110.1M103.0M174.4M
Operating income441.8M373.2M569.7M416.6M499.4M513.1M263.1M161.7M142.1M149.5M
Depreciation and amortization223.6M204.9M141.0M115.6M91.6M95.7M91.3M91.8M90.5M77.2M
EBITDA665.4M578.1M710.8M532.2M590.9M608.9M354.4M253.4M232.6M226.7M
Interest expense35.2M33.0M26.7M29.0M24.3M27.7M25.1M17.7M15.9M10.4M
Income before tax470.7M368.3M571.2M413.8M487.8M510.9M259.9M161.9M144.5M178.5M
Income tax38.5M56.2M40.0M54.2M71.4M36.1M20.9M19.7M25.2M
Net income400.5M300.7M453.6M346.7M412.8M398.2M194.4M119.0M104.9M132.8M
Earnings per share, basic0.860.650.980.751.031.010.490.290.260.34

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents651.2M487.4M335.4M384.4M1.31B294.5M396.4M287.9M397.8M295.0M
Short-term investments1.04B1.45B1.28B1.50B577.9M399.8M385.3M277.2M207.8M263.6M
Receivables983.6M1.14B1.02B742.5M606.6M466.6M373.1M399.8M351.1M312.7M
Inventory502.1M499.6M389.9M367.1M360.5M364.0M263.6M258.3M236.8M218.9M
Current assets3.37B3.65B3.26B3.09B3.06B1.60B1.53B1.36B1.32B1.17B
Property, plant and equipment1.30B1.11B1.03B953.9M929.3M935.6M
Goodwill443.0M442.3M67.8M67.8M67.8M67.8M67.8M67.8M67.8M70.1M
Total assets7.66B7.97B6.60B6.11B5.69B3.90B3.56B3.00B2.92B2.73B
Accounts payable436.8M550.2M562.0M148.5M65.4M22.2M201.6M203.6M175.6M173.1M
Current liabilities1.89B2.25B1.34B1.31B1.12B877.2M1.05B665.5M657.3M518.1M
Long-term debt368.4M513.8M307.1M191.2M90.1M98.1M55.3M9.23M15.4M
Total debt1.32B872.1M877.7M739.0M560.6M638.1M353.6M388.2M254.9M
Total liabilities2.47B2.96B1.79B1.61B1.37B1.16B1.21B744.0M748.0M627.7M
Shareholders' equity4.70B4.47B4.50B4.22B4.03B2.46B2.12B2.01B1.95B1.90B
Shares outstanding464.8M460.3M463.5M463.0M402.4M396.0M397.1M404.6M404.5M394.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations297.5M735.5M378.2M389.5M382.6M388.4M383.6M174.9M107.6M207.7M
Capital spending-176.1M-185.3M-244.5M-372.4M-305.9M-259.2M-229.7M-112.4M-108.9M-128.1M
Free cash flow121.4M550.2M133.7M17.1M76.8M129.3M153.9M62.4M-1.30M79.5M
Cash from investing-451.7M-161.0M-1.24B-627.1M-243.1M-397.8M-145.4M-58.3M-450.0M
Cash from financing-133.3M-272.5M-48.3M1.26B-169.9M92.6M-125.9M76.9M294.6M
Dividends paid-167.5M-215.8M-162.8M-163.7M-160.1M-100.1M-60.7M-80.3M-75.1M-70.0M
Share buybacks-115.1M-44.9M-1.79M-915.9K-100.5M
Change in cash149.3M151.3M-55.2M-903.5M1.02B-24.5M78.5M-96.5M126.2M52.3M